These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27815440)

  • 21. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
    Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
    Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN.
    Shen L; Suresh L; Malyavantham K; Kowal P; Xuan J; Lindemann MJ; Ambrus JL
    J Immunol; 2013 Jul; 191(2):608-13. PubMed ID: 23772034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
    St Clair EW; Baer AN; Wei C; Noaiseh G; Parke A; Coca A; Utset TO; Genovese MC; Wallace DJ; McNamara J; Boyle K; Keyes-Elstein L; Browning JL; Franchimont N; Smith K; Guthridge JM; Sanz I; James JA;
    Arthritis Rheumatol; 2018 Sep; 70(9):1470-1480. PubMed ID: 29604186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation.
    Mingueneau M; Boudaoud S; Haskett S; Reynolds TL; Nocturne G; Norton E; Zhang X; Constant M; Park D; Wang W; Lazure T; Le Pajolec C; Ergun A; Mariette X
    J Allergy Clin Immunol; 2016 Jun; 137(6):1809-1821.e12. PubMed ID: 27045581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-Resident Memory CD8+ T Cells Acting as Mediators of Salivary Gland Damage in a Murine Model of Sjögren's Syndrome.
    Gao CY; Yao Y; Li L; Yang SH; Chu H; Tsuneyama K; Li XM; Gershwin ME; Lian ZX
    Arthritis Rheumatol; 2019 Jan; 71(1):121-132. PubMed ID: 30035379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
    Alunno A; Bistoni O; Bartoloni Bocci E; Caterbi S; Bigerna B; Pucciarini A; Tabarrini A; Mannucci R; Beghelli D; Falini B; Gerli R
    Reumatismo; 2013 Oct; 65(4):192-8. PubMed ID: 24192564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T lymphocyte subsets of the infiltrating cells in the salivary gland and kidney of a patient with Sjögren's syndrome associated with interstitial nephritis.
    Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Taniguchi R; Tomino Y; Arimori S
    Clin Exp Rheumatol; 1985; 3(3):259-63. PubMed ID: 3876902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
    Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
    Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome.
    Kwok SK; Cho ML; Her YM; Oh HJ; Park MK; Lee SY; Woo YJ; Ju JH; Park KS; Kim HY; Park SH
    Arthritis Res Ther; 2012 Mar; 14(2):R64. PubMed ID: 22417709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.
    Bolstad AI; Le Hellard S; Kristjansdottir G; Vasaitis L; Kvarnström M; Sjöwall C; Johnsen SJ; Eriksson P; Omdal R; Brun JG; Wahren-Herlenius M; Theander E; Syvänen AC; Rönnblom L; Nordmark G; Jonsson R
    Ann Rheum Dis; 2012 Jun; 71(6):981-8. PubMed ID: 22294627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
    Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
    Front Immunol; 2020; 11():594658. PubMed ID: 33603736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
    Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
    Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
    Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
    Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lymphocyte subsets in labial salivary gland of Sjogren's syndrome].
    Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):83-8. PubMed ID: 8242827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
    Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
    Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
    J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
    Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
    J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.